According to investigators at St. Jude Children’s Research Hospital, comprehensive genomic screening may be warranted for all pediatric cancer patients, not just those with a family history of cancer, based on a detailed analysis of the role of germline mutations in genes associated with cancer predisposition.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
